Healthcare ❯Pharmaceuticals ❯Clinical Trials

Weight Loss Drugs

Market Competition Structure Therapeutics Drug Development GLP-1 Receptor Agonists

New Studies Confirm Safety of Semaglutide for Mental Health

Research from Sweden and the U.S. finds no significant link between semaglutide-based drugs and increased risk of depression or suicidal behavior.

Zealand Pharma's Petrelintide Shows Promising Results in Early Weight Loss Trial

Viking Therapeutics' Weight Loss Drug Shows Promise in Early Trial